A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics

dc.authoridErtan Yetkin / 0000-0001-8862-750X
dc.authoridHasan Turhan / 0000-0003-1658-9449
dc.authoridBilal Çuğlan / 0000-0003-0581-4946
dc.authorscopusidErtan Yetkin / 7004009443
dc.authorscopusidHasan Turhan / 7003487752
dc.authorscopusidBilal Çuğlan / 36650312600
dc.authorwosidErtan Yetkin / AGX-3712-2022
dc.authorwosidHasan Turhan / ACW-0041-2022
dc.authorwosidBilal Çuğlan / AAP-8878-2021
dc.contributor.authorYetkin, Ertan
dc.contributor.authorÇuğlan, Bilal
dc.contributor.authorTurhan, Hasan
dc.contributor.authorÖztürk, Selçuk
dc.date.accessioned2020-08-30T20:06:10Z
dc.date.available2020-08-30T20:06:10Z
dc.date.issued2020
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractImprovements in the medical management of heart failure have changed the course of the disease. However, mortality rates, hospitalization rates, and treatment costs are not at desired levels. Diuretics have been widely used in the treatment of congestion in heart failure patients. The following case reports represent a special patient group treated and followed by cardiology clinic. Treatment approach of each case report has been tailored on an individual basis depending on the clinical course and hospitalization rates of patients. Authors have highlighted and discussed the common aspects and future perspectives of their cases in which post-discharge intermittent empirical intravenous diuretic administration dramatically improved the clinical status and readmission number due to decompensated congestive heart failure. This is a relatively new and promising approach, which has been thought to cease the recycle of diuretic resistance and silent increase of fluid congestion in patients with congestive heart failure and frequent hospitalization. Copyright (c) 2020 Wolters Kluwer Health, Inc. All rights reserved.en_US
dc.identifier.citationYetkin, E., Cuglan, B., Turhan, H., & Ozturk, S. (2020). A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics. CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 9(2), 60–63. https://doi.org/10.1097/XCE.0000000000000200en_US
dc.identifier.doi10.1097/XCE.0000000000000200en_US
dc.identifier.endpage63en_US
dc.identifier.issn2574-0954en_US
dc.identifier.issue2en_US
dc.identifier.pmid32537567en_US
dc.identifier.scopus2-s2.0-85090449839en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage60en_US
dc.identifier.urihttps://doi.org/10.1097/XCE.0000000000000200
dc.identifier.urihttps://hdl.handle.net/20.500.12713/400
dc.identifier.volume9en_US
dc.identifier.wosWOS:000537105100005en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorYetkin, Ertanen_US
dc.institutionauthorÇuğlan, Bilalen_US
dc.institutionauthorTurhan, Hasanen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofCardiovascular Endocrinology & Metabolismen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDiuretic Therapyen_US
dc.subjectFurosemideen_US
dc.subjectHeart Failureen_US
dc.subjectHospitalizationen_US
dc.subjectIntermittenten_US
dc.titleA novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diureticsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
69a.pdf
Boyut:
135.12 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text